{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Up to 17 parameters in one test strip Comprehensive test panels for the detection of ANA, ALD, Vasculitis, Myositis, and Diabetes Unique control band on test strips can generate semi-quantitative ...
Result display time: 60 min
Sample volume: 0.01 ml
... CytoBead® ANCA is an immunofluorescence assay (IFA) for the qualitative and semi-quantitative determination of IgG antibodies in human serum against neutrophil cytoplasmic antigens (ANCA) and the glomerular ...
Result display time: 80 min
... cytoplasmic antibodies (ANCA) play an essential role in the serological diagnosis of SV. These antibodies are usually determined by indirect immunofluorescence using ethanol fixed human neutrophils. Cytoplasmic ANCA ...
AESKUSLIDES® ANCA is an indirect immunofluorescence assay to detect anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum. The assay is a tool for the differential diagnosis of ANCA-associated ...
AESKU.GROUP
The AESKUBLOTS® test line represents a variety of different immunoblots for an effcient sample testing of autoimmune and infectious diseases. Being coated with a plethora of specifc antigens on one test ...
AESKU.GROUP
Vasculitis (ANCA-PR3, ANCA - MPO, GM) Regulatory Status (USA):510(k) Cleared Discipline:Autoimmune Vasculitis (bulk pack) Regulatory Status (USA):510(k) Cleared Discipline:Autoimmune
Please specify:
Help us improve:
remaining